阿特佐利祖马布加贝瓦西祖马布组合治疗不可切除的肝细胞癌:一个机构经验
Abdullah Esmail1,2, Yazan Hamadneh3, Bayan Khasawneh1
1Section of GI Oncology, Department of Medicine, Houston Methodist Cancer Center, Houston, TX 77030, USA.
Biomedicines
|December 30, 2025
概括
现实世界的数据显示,阿特佐利祖马布加贝瓦齐祖马布 (Atezo/Bev) 对不可切除的肝细胞癌 (uHCC) 提供了显著的生存益处. 这种组合疗法表现出可控的毒性,特别是在肝功能良好或接受多模式治疗的患者中.
科学领域:
- 肝细胞癌 (HCC) 研究研究
- 胃肠病学和肝病学
- 瘤学和癌症治疗疗法
背景情况:
- 肝细胞癌 (HCC) 仍然是全球癌症相关死亡的主要原因.
- 阿特佐利祖马布加贝瓦西祖马布 (Atezo/Bev) 是一种被认可的第一线治疗不可切除的HCC (uHCC),在临床试验中显示出更好的生存结果.
研究的目的:
- 评估Atezo/Bev治疗在被诊断患有不可切除的HCC (uHCC) 的患者中的实际有效性和安全性.
- 确定在临床环境中可能从Atezo/Bev治疗中受益最多的患者子组.
主要方法:
- 从2020年1月到2023年6月,对87名无法切除的HCC患者进行了回顾性分析,这些患者接受了Atezo/Bev治疗.
- 收集的数据包括患者人口统计数据,治疗细节,放射性反应,总生存期 (OS),无进展生存期 (PFS) 和不良事件.
- 治疗遵循FDA的指导方针:阿特佐利祖马布1200毫克加贝瓦齐祖马布15毫克/公斤每3周一次.
主要成果:
- 中位数OS为15.1个月,中位数PFS为9.1个月. 目标响应率为31.3%.
- 患有Child-Pugh A级肝功能患者 (21.2个月) 和接受Atezo/Bev局部治疗后患者 (21.2个月) 的患者的寿命显著更长.
- 毒性导致14%的患者停止治疗,主要是由于胃肠道出血和疲劳.
结论:
- 在治疗不可切除的HCC (uHCC) 方面,Atezo/Bev在现实世界表现出有利的疗效.
- 这种治疗与可控毒性有关,特别有利于肝功能保留或接受多式疗法的患者.
关键词:
孩子的Pugh 的它们是Atezolizumab.这是bevacizumab的治疗方法.肝细胞癌是肝细胞癌.免疫检查点抑制剂 免疫检查点抑制剂地方区域治疗疗法总体存活率 总体存活率没有进展的生存率.现实世界的证据.不能切除的HCC是不可切除的更多相关视频
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
10.7K
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
1.0K
相关概念视频
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K